Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print A search for biomarkers for early detection of colorectal cancer

A search for biomarkers for early detection of colorectal cancer

September 25, 2007

Researchers at the Zhejiang University, Hangzhou have discovered that mimecan and Thioredoxin Domain-Containing Protein 5 (TXNDC5) were differentially expressed in colorectal adenoma. The research article describing this work entitled "Differential Expression of Mimecan and Thioredoxin Domain-Containing Protein 5 in Colorectal Adenoma and Cancer: A Proteomic Study" will be featured in the October 2007 issue of Experimental Biology and Medicine.

Adenoma is the major precursor lesion of colorectal cancer, one of the most common cancers worldwide. The elucidation of the molecular mechanism underlying adenoma is essential for early detection, prevention and intervention of colorectal cancer.




The research team, led by Maode Lai, a professor of molecular pathology, found 27 differentially expressed proteins in colorectal adenoma using two dimensional electrophoresis (2-DE) and mass spectrometry. Western-blot analysis clearly validated 2 differentially expressed proteins, mimecan downregulation and TXNDC5 upregulation in colorectal adenomas and cancers.

"Adenoma is a very important step in the development of cancer. Discovering the biomarker of adenoma will improve the early detection and prevention of cancer," said Lai. "2-DE is an efficient traditional approach for the identification of differentially expressed proteins in cancer biology. Using this technology, we first identified 27 differentially expressed proteins in individual-matched colorectal normal, adenoma and cancer tissues."

"This study found two novel proteins which have never been found to be associated with colorectal cancer. We clearly demonstrated that absence of mimecan and up-regulation of TXNDC5 were involved in the early development of colorectal cancer," said the article's first author Yinghong Wang. "Our further work showed that mimecan can inhibit cell growth and induce cell apoptosis in colorectal cancer cells implying a candidate role as a tumor suppressor gene for the mimecan gene. These results suggested that mimecan might serve as a potential biomarker for future gene therapy."

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "Lai and his colleagues have performed a protein profiling proteomic study to understand the molecular mechanisms leading to colorectal cancer. It is this type of approach which can lead to the identification of biomarkers for the early detection of colorectal cancer, and targets for future gene therapy".

Society for Experimental Biology and Medicine



Related Colorectal Cancer Current Events and Colorectal Cancer News Articles Colorectal Cancer Current Events and Colorectal Cancer News RSS Colorectal Cancer Current Events and Colorectal Cancer News RSS
Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News (GEN).

New screening technologies improve detection of polyps during colonoscopy
Two studies presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando highlight new technologies with the potential to improve the detection of colorectal polyps and flat lesions during colonoscopy.

Metabolic syndrome ups colorectal cancer risk
In a large U.S. population-based study presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.

Study confirms colonoscopy associated with reduced colorectal cancer incidence
Patients who undergo a complete negative colonoscopy have a reduced incidence of colorectal cancer, confirms a study published in Clinical Gastroenterology and Hepatology.

Surgical treatment provides new option for some colorectal cancer patients
Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.

Black Americans Are At Greater Risk for Colon Polyps
Black Americans have a higher occurrence of colon polyps, according to a new study. This is a significant finding considering the incidence of colon cancer among black men has increased and remained unchanged among black women during the last 20 years.

Racial disparities decline for cancer in Missouri
Cancer death rates in the United States are highest among African Americans, but a new report shows that in Missouri the disparity in cancer incidence and death between African Americans and whites is declining.

Risk of colorectal cancer extremely low 5 years after a normal colonoscopy screening
A study appearing in the Sept. 18 issue of the New England Journal of Medicine shows that among individuals with no colorectal neoplasia (abnormal growths) on initial screening colonoscopy, the five-year risk of colorectal cancer is extremely low.

Severe stress more common among long-term cancer survivors
Long-term survivors of adult cancers are almost twice as likely to report psychological distress severe enough to cause moderate to serious problems functioning in social, work or school situations, compared to the general population.

Cancer-causing gut bacteria exposed
Normal gut bacteria are thought to be involved in colon cancer but the exact mechanisms have remained unknown. Now, scientists from the USA have discovered that a molecule produced by a common gut bacterium activates signalling pathways that are associated with cancer cells.
More Colorectal Cancer Current Events and Colorectal Cancer News Articles


Be a Survivor: Colorectal Cancer Treatment Guide (Be a Survivor)
by Vladimir Lange

Dr. Lange’s comprehensive overview of cancer and treatment options offers detailed information using simple, concise language and a wide variety of color photos and drawings. Colorectal cancer patients need to know more about their disease, yet there is an overload of information. Be a Survivor gives the patient the specific, reliable and necessary information to make good decisions about their...



Positive Options for Colorectal Cancer: Self-Help and Treatment
by Carol Ann Larson

Colorectal cancer develops slowly over a period of several years, undetected, usually as polyps. It is a preventable and treatable disease if caught in time, yet most know little about how to read its symptoms. Written for the layperson, this book covers all the uncomfortable questions and answers about the disease, from prevention and warning signs, to screening and diagnosis techniques, to...



Challenges in Colorectal Cancer

The latest guidance on challenging and controversial aspects of colorectal cancer Colorectal cancer is one of the most common forms of cancer in the US and Europe. Thousands of people are diagnosed with the disease every year and nearly half of these die as a result. As colorectal cancer is curable when detected early, a significant proportion of these deaths could be prevented by earlier...



The Intelligent Patient Guide to Colorectal Cancer: Information, risk, prevention, symptoms, signs, diagnosis, stage, surgery, radiation, chemotherapy, prognosis, treatment of/for colon rectal cancer.
by Michael E. Pezim, David A. Owen

The Intelligent Patient Guide book series was created in 1989 by a group of American and Canadian-trained physicians frustrated by the lack of quality information available for their cancer patients. The books became bestsellers, and their appeal has grown despite the development of the Internet. Whereas the Internet is an explosion of medical information that can confuse and intimidate, these...



100 Questions & Answers About Colorectal Cancer
by Susannah ROse, W. Douglas Wong David S. Bub



American Cancer Society's Complete Guide to Colorectal Caner
by American Cancer Society

Don't die of embarrassment--get informed about colorectal cancer Although colorectal cancer is the third most common cancer found in men and women, you may be unaware of your risk and don't know what you can do to prevent this serious disease. You may be too embarrassed to ask your doctor about changes in your bowel habits or get screened for colorectal cancer. American Cancer Society's Complete...



Colorectal Cancer (Contemporary Issues in Cancer Imaging)

Colorectal cancer is the second most common cause of cancer death in the developed world. The last five years have seen dramatic improvements in the multidisciplinary management of this malignancy. In this volume, experts at the forefront of these advances contribute their knowledge and experience on the major advances that have occurred in diagnosis, staging, preoperative and adjuvant therapy,...



What Your Doctor May Not Tell You About(TM) Colorectal Cancer: New Tests, New Treatments, New Hope (What Your Doctor May Not Tell You About...)
by Mark Bennett Pochapin

The latest edition in the bestselling What Your Doctor May Not Tell You series explodes the myths and misconceptions about the third most common-and second most deadly-form of cancer in the United States. Over 50,000 men and women die from colorectal cancer each year-a particularly alarming statistic since it is also one of the most preventable and treatable cancers. In fact, it is estimated that...

100 Questions & Answers About Colorectal Cancer
by David Bub, Susannah Rose, W. Douglas Wong

This book is a patient-oriented guide to dealing with colorectal cancer. A question and answer format is used to cover many topics related to this...



Colorectal Cancer, An Issue of Surgical Oncology Clinics (The Clinics: Surgery)
by Tom Anthony

Important developments have been made to the field of colon and rectal cancer, including molecular markers and neo-adjuvant therapy, plus additional improvements to preventive measure and screening strategies. Each of the thirteen articles is authored by a leading surgeon in the field, addressing everything from pathogenesis to the patient-centered outcomes. The entire issue provides the reader...

© 2008 BrightSurf.com